“Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances”-Reference-Cited by-同舟云学术

“Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances”

Published:2016-06 Issue:6 Volume:42 Page:869-876
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Arjona-Sánchez A.,Cadenas-Febres A.,Cabrera-Bermon J.,Muñoz-Casares F.C.,Casado-Adam A.,Sánchez-Hidalgo J.M.,López-Andreu M.,Briceño-Delgado J.,Rufián-Peña S.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference24 articles.

1. Peritoneal carcinomatosis from non-gynecologic malignancies results of the EVOCAPE 1 multicentric prospective study;Sadeghi;Cancer,2000

2. Peritonectomy procedure;Sugarbaker;Ann Surg,1995

3. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;Canda;Ann Surg Oncol,2013

4. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality;Chua;Ann Surg,2009

5. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group;Bellomo;Crit Care,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A systematic review;European Journal of Surgical Oncology;2024-12

2. Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-28

3. Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy;International Journal of Hyperthermia;2024-02-11

4. Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience;International Journal of Gynecologic Cancer;2023-11-27

5. Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;Langenbeck's Archives of Surgery;2023-01-17